Individualized rTMS for Motor Recovery in Stroke Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Repetitive transcranial magnetic stimulation.
- Who it may be relevant to
- Registry conditions: Stroke, Transcranial Magnetic Stimulation. Basic parameters: from 20 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficacy of Individualized Repetitive Transcranial Magnetic Stimulation Based on Cortical Laterality for Motor Recovery in Stroke Patients
Overview
This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.
Detailed description
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology.
High and low frequencies of rTMS could modulate the excitability of the cerebral cortex. Theta burst stimulation (TBS) has achieved a similar effect to traditional rTMS mode.
However, the current rTMS studies for stroke patients utilized the same therapeutic protocol and there is no individualized rTMS protocol based on the value of lateralization index.
This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.
Interventions
- Device Repetitive transcranial magnetic stimulation
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. High and low frequencies of rTMS could modulate the excitability of the cerebral cortex.
Primary outcome measures
- Fugl-Meyer Assessment [Time frame: 12 weeks post intervention]
Secondary outcome measures (7)
- Medical Research Council (MRC) Scale for Muscle Strength [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
- National Institutes of Health Stroke Scale [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
- Barthel Index [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
- Modified Rankin Scale [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
- MEP [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
- Fugl-Meyer Assessment [Time frame: 1 week, 4 weeks post intervention]
- functional NIRS [Time frame: 1 week, 4 weeks, 12 weeks post intervention]
Eligibility criteria
Inclusion criteria
- Unilateral ischemic or hemorrhagic stroke
- Stroke within 3 months
- Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
- No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
- Patient could sit over 15 minutes
- Age over 20
Exclusion criteria
- Previous stroke, traumatic brain injury, brain tumor
- With central nervous system disease (spinal cord injury, Parkinson's disease)
- Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
- Patients unable to cooperate the treatment
- Pregnancy
- Depression
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Taiwan · 1 center
- National Taiwan University Hospital — Taipei County
Identifiers
NCT: NCT05914038 · 202301225DIND